The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Twenty years post‐NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual: Renewing the case for enhancing minority participation in cancer clinical trials
Open accessAbstract
BACKGROUND: The National Institutes of Health (NIH) Revitalization Act of 1993 mandated the appropriate inclusion of minorities in all NIH‐funded research. Twenty years after this act, the proportion of minority patients enrolled in cancer clinical trials remains persistently low. Clinical trials are vehicles for the development and evaluation of therapeutic and preventive agents under scientifically rigorous conditions. Without representation in trials, it is projected that disparities in the cancer burden for minorities will increase. METHODS: For this review article, the authors counted the frequency with which minorities were the primary focus of National Cancer Institute‐sponsored clinical trials, examined citations from the PubMed database focusing on the search terms “NIH Revitalization Act of 1993” and “enhancing minority accrual to cancer clinical trials,” and supplemented the review with their expertise in NIH‐funded research related to minority accrual in cancer clinical trials. RESULTS: The reporting and analyses of data based on minorities in clinical trials remain inadequate. Less than 2% of the National Cancer Institute's clinical trials focus on any racial/minority population as their primary emphasis. The current review of the literature indicated that the percentage of authors who reported their study sample by race/ethnicity ranged from 1.5% to 58%, and only 20% of the randomized controlled studies published in a high‐impact oncology journal reported analyzing results by race/ethnicity. Proportionately greater population increases in minorities, accompanied by their persistent and disproportionate cancer burden, reinforce the need for their greater representation in clinical trials. CONCLUSIONS: Renewing the emphasis for minority participation in clinical trials is warranted. Policy changes are recommended. Cancer 2014;120(7 suppl):1091–6. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review
Ford, J. G., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., Tilburt, J., Baffi, C., Tanpitukpongse, T. P., Wilson, R. F., et al. (2008) · Cancer · doi:10.1002/cncr.23157 · Cited by 1,083
Jemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?
Wendler, D., Kington, R., Madans, J., Wye, G. V., Christ-Schmidt, H., Pratt, L. A., Brawley, O. W., Gross, C. P., & Emanuel, E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030019 · Cited by 854
Cancer statistics for Hispanics/Latinos, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21153 · Cited by 655
Why ethnic minority groups are under-represented in clinical trials: A review of the literature
Hussain-Gambles, M., Atkin, K., & Leese, B. (2004) · Health and Social Care in the Community · doi:10.1111/j.1365-2524.2004.00507.x · Cited by 447
Geller, S. E., Koch, A., Pellettieri, B., & Carnes, M. (2011) · Journal of Women's Health · doi:10.1089/jwh.2010.2469 · Cited by 374
Cited by
Cancer statistics for African Americans, 2019
DeSantis, C. E., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21555 · Cited by 743
Race and Genetic Ancestry in Medicine — A Time for Reckoning with Racism
Borrell, L. N., Elhawary, J. R., Fuentes-Afflick, E., Witonsky, J., Bhakta, N., Wu, A. H. B., Bibbins-Domingo, K., Rodríguez-Santana, J. R., Lenoir, M. A., Gavin, J. R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmms2029562 · Cited by 656
Diversity in clinical and biomedical research: a promise yet to be fulfilled
Oh, S. S., Galanter, J., Thakur, N., Pino-Yanes, M., Barcelo, N. E., White, M. J., de Bruin, D. M., Greenblatt, R. M., Bibbins-Domingo, K., Wu, A. H. B., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001918 · Cited by 585
Loree, J. M., Anand, S., Dasari, A., Unger, J. M., Gothwal, A., Ellis, L. M., Varadhachary, G., Kopetz, S., Overman, M. J., & Raghav, K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1870 · Cited by 570
Cancer statistics for African American/Black People 2022
Giaquinto, A. N., Miller, K. D., Tossas, K. Y., Winn, R. A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21718 · Cited by 574
A framework for enhancing ethical genomic research with Indigenous communities
Claw, K. G., Anderson, M. Z., Begay, R. L., Tsosie, K. S., Fox, K., Garrison, N. A., Summer internship for INdigenous peoples in Genomics (SING) Consortium, Bader, A. C., Bardill, J., Bolnick, D. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05188-3 · Cited by 484
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Duma, N., Vera Aguilera, J., Paludo, J., Haddox, C. L., Gonzalez Velez, M., Wang, Y., Leventakos, K., Hubbard, J. M., Mansfield, A. S., Go, R. S., et al. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.025288 · Cited by 446
Race/ethnicity reporting and representation in US clinical trials: A cohort study
Turner, B. E., Steinberg, J. R., Weeks, B. T., Rodriguez, F., & Cullen, M. R. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100252 · Cited by 395
Axes of a revolution: challenges and promises of big data in healthcare
Shilo, S., Rossman, H., & Segal, E. (2020) · Nature Medicine · doi:10.1038/s41591-019-0727-5 · Cited by 370
Racial/ethnic differences in drug disposition and response: Review of recently approved drugs
Ramamoorthy, A., Pacanowski, M., Bull, J., & Zhang, L. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.61 · Cited by 341
Geller, S. E., Koch, A. R., Roesch, P., Filut, A., Hallgren, E., & Carnes, M. (2018) · Academic Medicine · doi:10.1097/acm.0000000000002027 · Cited by 314
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Islami, F., Guerra, C. E., Minihan, A., Yabroff, K. R., Fedewa, S. A., Sloan, K., Wiedt, T. L., Thomson, B., Siegel, R. L., Nargis, N., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21703 · Cited by 264
Nazha, B., Mishra, M., Pentz, R., & Owonikoko, T. K. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100021 · Cited by 257
Underrepresentation of Hispanics and Other Minorities in Clinical Trials: Recruiters’ Perspectives
Occa, A., Morgan, S. E., & Potter, J. E. (2018) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-017-0373-x · Cited by 78
Haley, S. J., Southwick, L. E., Parikh, N. S., Rivera, J., Farrar-Edwards, D., & Boden-Albala, B. (2017) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-016-0332-y · Cited by 73
Hindorff, L. A., Bonham, V. L., & Ohno-Machado, L. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0037 · Cited by 58
Reihl, S. J., Patil, N., Morshed, R. A., Mehari, M., Aabedi, A., Chukwueke, U. N., Porter, A. B., Fontil, V., Cioffi, G., Waite, K., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac011 · Cited by 46
Lovell, H., Silverio, S. A., Story, L., Skelton, E., & Matthew, J. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282088 · Cited by 39
Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer
Eskander, M. F., Gil, L., Beal, E. W., Li, Y., Hamad, A., Oppong, B., Obeng-Gyasi, S., & Tsung, A. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10868-4 · Cited by 35
Hernandez, N. D., Durant, R., Lisovicz, N., Nweke, C., Belizaire, C., Cooper, D., Soiro, F., Rivers, D., Sodeke, S., & Rivers, B. M. (2022) · Journal of Cancer Education · doi:10.1007/s13187-021-01994-4 · Cited by 26
Thetford, K., Gillespie, T. W., Kim, Y.-I., Hansen, B., & Scarinci, I. C. (2021) · Ethnicity & Disease · doi:10.18865/ed.31.2.263 · Cited by 25
Addison, S., Yang, Y., Metlock, F., King, M., McKoy, A., Williams, A., Gregory, J., Gray, D. M., Joseph, J. J., & Nolan, T. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912041 · Cited by 17
Batchelor, W. B., Damluji, A. A., Yong, C., Fiuzat, M., Barnett, S. D., Kandzari, D. E., Sherwood, M. W., Epps, K. C., Tehrani, B. N., Allocco, D. J., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.02.003 · Cited by 7
Perceptions of clinical care and research among African-American patients with lymphoma
Dance, K. V., Imbody, C. B., Chen, L., McNeill, L., Payne, J. B., & Flowers, C. R. (2021) · Leukemia & Lymphoma · doi:10.1080/10428194.2021.1892092 · Cited by 7
Marrast, L., Conigliaro, J., Chan, C., Kim, E. J., Duer-Hefele, J., Diefenbach, M. A., & Davidson, K. W. (2021) · Personalized Medicine · doi:10.2217/pme-2020-0166 · Cited by 6
The problem with one-size-fits-all medicine: biological sex and the aging immune system
Baker, C., Ansere, V. A., Sanqui, C. I., & Benayoun, B. A. (2026) · PLOS Biology · doi:10.1371/journal.pbio.3003763 · Cited by 3
“Yet females and individuals from other minorities remained underrep-resented in aging studies, including vaccine and immune trials [140].”
Metadata
- Authors
- Chen, M. S., Lara, P. N., Dang, J. H. T., Paterniti, D. A., & Kelly, K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-03-18
- Volume
- 120
- Issue
- S7
- Pages
- 1091-1096
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1805776597
- Cited by
- 472
- References
- 28
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.